本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

麦赛斯医药

4.25
-0.4500-9.57%
成交量:1.02万
成交额:4.43万
市值:4.63亿
市盈率:-5.50
高:4.75
开:3.80
低:3.80
收:4.70
52周最高:11.80
52周最低:3.00
股本:1.09亿
流通股本:6,799.44万
量比:0.12
换手率:0.02%
股息:- -
股息率:- -
每股收益(TTM):-0.7726
每股收益(LYR):-0.7714
净资产收益率:-1.69%
总资产收益率:-0.62%
市净率:0.46
市盈率(LYR):-5.51

数据加载中...

2024/12/31

重要事件披露

Form 8-K - Current report
2024/11/15

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

重要事件披露

Form 8-K - Current report
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/31

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/12

重要事件披露

Form 8-K - Current report
2024/07/29

重要事件披露

Form 8-K - Current report
2024/06/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/28

重要事件披露

Form 8-K - Current report
2024/05/16

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/25

重要事件披露

Form 8-K - Current report
2024/04/25

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2024/04/10

重要事件披露

Form 8-K - Current report
2024/04/01

重要事件披露

Form 8-K - Current report
2024/03/13

重要事件披露

Form 8-K - Current report
2024/03/12

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/11

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]